Download PDF
CC BY-NC-ND 4.0 · South Asian J Cancer
DOI: 10.1055/s-0045-1802983
Letter to the Editor

Lung Cancer Sessions in Annual Conferences: Need for Better Interactions and Collaboration between Oncologists and Pulmonologists

Jayamol Revendran
1   Department of Respiratory Medicine, Sree Balaji Medical College and Hospital, Chennai, Tamil Nadu, India
,
Sujith Kumar Mullapally 
2   Department of Medical Oncology, Apollo Proton Cancer Centre, Chennai, Tamil Nadu, India
› Author Affiliations
› Further Information
Also available at
 
 PDF Download Permissions and Reprints
Zoom Image
Jayamol Revendran

There is increasing role of molecular oncology in lung cancers. There is also need for increased awareness on molecular oncology and therapeutic implications among pulmonologists. Immunotherapy and targeted therapies have potential complications like pneumonitis and interstitial lung diseases. Advances in pulmonology like rapid onsite evaluation can potentially decrease the delay in molecular diagnosis as the tissue can be send early without waiting for conventional histological diagnosis.1Role of artificial intelligence in lung cancer for screening and early diagnosis is emerging of which oncologists need to be aware.

In October 2024, the national conference of medical oncologists was held in New Delhi (ISMPOCON), and in November 2024, the national conference of pulmonologists (NAPCON) was held at Coimbatore. Analysis of lung cancer dedicated hours in the total sessions of these conferences, showed that in ISMPOCON, out of total 110 hours of academic discussions, 9 (8%) was dedicated to lung cancer. Among the faculty invited, there was only one pulmonologist. In NAPCON 2024, total hours of lung cancer sessions were 8 hours (4%) out of 216 hours. The number of oncologists in the invited faculty was 0. Sessions on artificial intelligence and nanotechnology in lung cancer were highlights of this conference.

Through this letter, we wish to emphasize the need for better collaboration and scientific interactions between the oncologists and pulmonologists in large scientific meetings like annual conferences where majority of the respective society members participate to improve scientific exchange of relevant clinical information and even lead on to research collaborations. Mutual invitation to clinical experts in pulmonology and oncology to talk regarding pertinent aspects of lung cancer will help in joint efforts to find solutions to the local challenges in lung cancer.


#

Conflict of Interest

None declared.

Acknowledgment

None.

  • Reference

  • 1 Revendran J, Mullapally SK. Advanced lung cancer: the scope(s) of the pulmonologist!. Cancer Res Stat Treat 2021; 4: 599-600
    CrossrefSearch in Google Scholar

Address for correspondence

Sujith Kumar Mullapally, MD, DNB, DM
Department of Medical Oncology, Apollo Proton Cancer Centre
Chennai 600041, Tamil Nadu
India   

Publication History

Received: 19 December 2024

Accepted: 17 January 2025

Article published online:
21 March 2025

© 2025. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

  • Reference

  • 1 Revendran J, Mullapally SK. Advanced lung cancer: the scope(s) of the pulmonologist!. Cancer Res Stat Treat 2021; 4: 599-600
    CrossrefSearch in Google Scholar

   Permissions and Reprints
Zoom Image
Jayamol Revendran